Associations between early in-hospital medications and the development of delirium in patients with stroke

J Stroke Cerebrovasc Dis. 2023 Sep;32(9):107249. doi: 10.1016/j.jstrokecerebrovasdis.2023.107249. Epub 2023 Aug 1.

Abstract

Objectives: Patients hospitalized with stroke develop delirium at higher rates than general hospitalized patients. While several medications are associated with existing delirium, it is unknown whether early medication exposures are associated with subsequent delirium in patients with stroke. Additionally, it is unknown whether delirium identification is associated with changes in the prescription of these medications.

Materials and methods: We conducted a retrospective cohort study of patients admitted to a comprehensive stroke center, who were assessed for delirium by trained nursing staff during clinical care. We analyzed exposures to multiple medication classes in the first 48 h of admission, and compared them between patients who developed delirium >48 hours after admission and those who never developed delirium. Statistical analysis was performed using univariate testing. Multivariable logistic regression was used further to evaluate the significance of univariately significant medications, while controlling for clinical confounders.

Results: 1671 unique patients were included in the cohort, of whom 464 (27.8%) developed delirium >48 hours after admission. Delirium was associated with prior exposure to antipsychotics, sedatives, opiates, and antimicrobials. Antipsychotics, sedatives, and antimicrobials remained significantly associated with delirium even after accounting for several clinical covariates. Usage of these medications decreased in the 48 hours following delirium identification, except for atypical antipsychotics, whose use increased. Other medication classes such as steroids, benzodiazepines, and sleep aids were not initially associated with subsequent delirium, but prescription patterns still changed after delirium identification.

Conclusions: Early exposure to multiple medication classes is associated with the subsequent development of delirium in patients with stroke. Additionally, prescription patterns changed following delirium identification, suggesting that some of the associated medication classes may represent modifiable targets for future delirium prevention strategies, although future study is needed.

Keywords: Delirium; Medications; Polypharmacy; Stroke.

MeSH terms

  • Antipsychotic Agents* / adverse effects
  • Delirium* / chemically induced
  • Delirium* / diagnosis
  • Hospitals
  • Humans
  • Hypnotics and Sedatives / therapeutic use
  • Retrospective Studies
  • Risk Factors
  • Stroke* / complications
  • Stroke* / diagnosis
  • Stroke* / drug therapy

Substances

  • Antipsychotic Agents
  • Hypnotics and Sedatives